Paper Details

  1. Home
  2. Paper Details

[Combination therapy with 5'DFUR and MPA as a second line treatment for advanced/recurrent breast cancer].

Author: ImaokaS, InajiH, IwanagaT, KoyamaH, MiyauchiK, NishizawaY, NoguchiS, YamamotoH

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
English AbstractA summary of a research paper/publication written in English for a wider audience.

Overview

Combination therapy with MPA and 5'DFUR is effective in treating recurrent breast cancer, with a 42% overall response rate. It is particularly effective for bone and visceral lesions. Side effects include obesity, edema, and diarrhea.
Paper Details　
Original Abstract of the Article :
As a second line therapy after failure to previous therapies, a combination therapy with MPA 1,200 mg po and 5'DFUR 1,200 mg po daily was given to 31 patients with recurrent breast cancer. At a median follow up period of 18 months, the overall response rate was 42%. The response rates for bone and v...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2141052

データ提供：米国国立医学図書館（NLM）

A New Oasis in Breast Cancer Treatment: 5'DFUR and MPA Combination Therapy

This study investigates the efficacy of a combination therapy with 5'DFUR and MPA in treating patients with advanced or recurrent breast cancer who have not responded to previous therapies. It's like seeking a new oasis in the desert of breast cancer treatment, exploring innovative approaches to combat this challenging disease.

A Second Chance: Exploring Combination Therapy for Breast Cancer

The study reveals that this combination therapy offers a significant response rate for patients with recurrent breast cancer, particularly those with bone or visceral lesions. This research highlights the potential of combination therapies in addressing advanced cancer, offering a beacon of hope for patients with limited treatment options. It's like finding a hidden spring in the desert of cancer treatment, providing a new source of hope for patients facing a difficult journey.

A Collaborative Approach: Combining Therapies for Optimal Outcomes

This study underscores the importance of exploring combination therapies in cancer treatment. It's a reminder that just as a camel relies on its resilience and adaptability to survive in the desert, we must be innovative and creative in our approach to combating cancer.

Dr.Camel's Conclusion

This study highlights the potential of a combination therapy with 5'DFUR and MPA in treating patients with advanced or recurrent breast cancer. It's a reminder that even in the vast and seemingly impenetrable desert of cancer treatment, there's always hope for new discoveries and innovative solutions.
Date :
  1. Date Completed 1990-07-13
  2. Date Revised 2015-11-23
Further Info :

Pubmed ID

2141052

DOI: Digital Object Identifier

2141052

Related Literature

Article Analysis
・Side Effects of floxuridine
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.